摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

托莫西汀杂质DEP标准品 | 873310-29-3

中文名称
托莫西汀杂质DEP标准品
中文别名
——
英文名称
N-methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine
英文别名
7Vqo06GR5Y;N-methyl-3-(3-methylphenoxy)-3-phenylpropan-1-amine
托莫西汀杂质DEP标准品化学式
CAS
873310-29-3
化学式
C17H21NO
mdl
——
分子量
255.36
InChiKey
JJKJMPPFRLCYEB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    托莫西汀杂质DEP标准品5-(ethoxymethylene)thiazolidine-2,4-dione三乙胺 作用下, 以 乙腈 为溶剂, 以96%的产率得到(Z)-5-((methyl(3-phenyl-3-(m-tolyloxy)propyl)amino)methylene)thiazolidine-2,4-dione
    参考文献:
    名称:
    An assembly of structurally diverse small and simple 5-aminomethylene derivatives of 2,4-thiazolidinedione and studies of their biological activity
    摘要:
    The synthesis of a novel series of substituted 5-(aminomethylene)thiazolidine-2,4-diones was achieved using a wide range of heterocyclic models derived from eight drug-like molecules. The primary aim of this study was to combine medicinally known, biologically active molecules bearing a 2A degrees amine functionality, such as terbinafine, fluoxetine, atomoxetine, cetirizine, risperidone, aripiprazole, ziprasidone, and clopidogrel, with a thiazolidinedione ring via an amino-methylene linker. By targeting this synergistic approach to compounds with skeletal, functional, and stereochemical diversity, we have developed a simple synthetic concept to enrich the thiazolidinedione collection with various biological activities. The biological activities of the newly synthesized 5-(aminomethylene)thiazolidine-2,4-dione derivatives were explored. All compounds were found to have antibacterial activity, with compounds bearing pyridine or piperazine moieties showing good to excellent antibacterial activity. Compounds with piperazine moieties were also found to show good antifungal activity, whereas none of the synthesized compounds showed high cytotoxic activity.
    DOI:
    10.1007/s00044-015-1447-0
  • 作为产物:
    参考文献:
    名称:
    Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards
    摘要:
    本发明提供了N-甲基-3-(3-甲基苯氧基)-3-苯基丙胺盐酸盐的分离物及其制备方法,以及N-甲基-3-(4-甲基苯氧基)-3-苯基丙胺盐酸盐和N-甲基-3-苯氧基-3-苯基丙胺盐酸盐的制备方法。本发明还提供了上述化合物在合成阿托莫西汀时作为参考标记物和/或参考标准的用途。还提供了一种限制在合成阿托莫西汀盐酸盐时使用的2-氟甲苯起始材料中杂质3FT(3-氟甲苯)、4FT(4-氟甲苯)和FB(氟苯)的数量的方法。通过使用标记物3-ATM HCl,确定2-氟甲苯起始材料中的3FT、4FT和FB的数量,以确保阿托莫西汀盐酸盐产品的纯度。
    公开号:
    US07378553B2
点击查看最新优质反应信息

文献信息

  • [EN] SYNTHESIS OF ATOMOXETINE HYDROCHLORIDE<br/>[FR] SYNTHESE D'HYDROCHLORURE D'ATOMOXETINE
    申请人:REDDYS LAB LTD DR
    公开号:WO2006037055A1
    公开(公告)日:2006-04-06
    (±)-Atomoxetine oxalate having crystalline Form II and a solid (±)-atomoxetine free base are useful in preparing atomoxetine hydrochloride.
    (±)-酒石酸阿托莫西汀II型晶体和固体(±)-阿托莫西汀游离碱在制备盐酸阿托莫西汀时是有用的。
  • Synthesis of Atomoxetine Hydrochloride
    申请人:Mathad Thippannachar Vijayavitthal
    公开号:US20080004470A1
    公开(公告)日:2008-01-03
    (±)-Atomoxetine oxalate having crystalline Form II and a solid (±)-atomoxetine free base are useful in preparing atomoxetine hydrochloride.
    (±)-草酸阿托莫西汀II型晶体和固体(±)-阿托莫西汀游离碱在制备阿托莫西汀盐酸盐时是有用的。
  • AN IMPROVED PROCESS FOR THE PREPARATION OF 3-ARYLOXY-3-PHENYLPROPYLAMINE AND SALT THEREOF
    申请人:ZCL CHEMICALS LIMITED
    公开号:US20160107983A1
    公开(公告)日:2016-04-21
    The present invention relates to an industrially feasible and economically viable process for the preparation of 3-aryloxy-3-phenylpropylarnine and salt of formula I thereof.
    本发明涉及一种工业可行且经济可行的制备3-芳氧基-3-苯基丙基胺及其盐的公式I的过程。
  • Verfahren zur Herstellung von Aryl-aminopropanolen
    申请人:Bayer Aktiengesellschaft
    公开号:EP1346977A1
    公开(公告)日:2003-09-24
    Die Erfindung betrifft ein Verfahren zur Herstellung von enantiomerenangereicherten Aryl-aminopropanolen und deren Verwendung sowie Zwischenprodukte.
    本发明涉及一种制备对映体富集的芳基氨基丙醇及其用途和中间体的工艺。
  • AN ISOLATED ATOMOXETINE IMPURITY, PROCESSES FOR THE PREPARATION OF ATOMOXETINE IMPURITIES AND THEIR USE AS REFERENCE STANDARDS
    申请人:Teva Pharmaceutical Fine Chemicals S.R.L.
    公开号:EP1761478A2
    公开(公告)日:2007-03-14
查看更多